CIBC Private Wealth Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $245M | Sell |
362,871
-7,668
| -2% | -$5.22M | 0.42% | 68 |
|
|
2025
Q3 | $237M | Sell |
370,539
-4,206
| -1% | -$2.55M | 0.41% | 71 |
|
|
2025
Q2 | $201M | Buy |
374,745
+271,193
| +262% | +$130M | 0.36% | 78 |
|
|
2025
Q1 | $37.4M | Buy |
103,552
+23,076
| +29% | +$10M | 0.08% | 191 |
|
|
2024
Q4 | $34.8M | Sell |
80,476
-97,450
| -55% | -$42.7M | 0.06% | 213 |
|
|
2024
Q3 | $89.9M | Sell |
177,926
-54,534
| -23% | -$26.5M | 0.16% | 133 |
|
|
2024
Q2 | $112M | Buy |
232,460
+57,945
| +33% | +$29.1M | 0.21% | 113 |
|
|
2024
Q1 | $92.9M | Sell |
174,515
-583
| -0.3% | -$319K | 0.18% | 125 |
|
|
2023
Q4 | $97.2M | Sell |
175,098
-1,296
| -0.7% | -$608K | 0.21% | 116 |
|
|
2023
Q3 | $77.1M | Sell |
176,394
-7,525
| -4% | -$3.75M | 0.18% | 119 |
|
|
2023
Q2 | $92.4M | Buy |
183,919
+4,630
| +3% | +$2.22M | 0.2% | 114 |
|
|
2023
Q1 | $81.2M | Sell |
179,289
-2,475
| -1% | -$1.18M | 0.18% | 127 |
|
|
2022
Q4 | $7.45M | Sell |
181,764
-4,506
| -2% | -$1.75M | 0.03% | 296 |
|
|
2022
Q3 | $60.7M | Sell |
186,270
-3,003
| -2% | -$1.1M | 0.16% | 129 |
|
|
2022
Q2 | $66.4M | Sell |
189,273
-74,750
| -28% | -$30.5M | 0.17% | 126 |
|
|
2022
Q1 | $144M | Sell |
264,023
-3,472
| -1% | -$1.83M | 0.32% | 81 |
|
|
2021
Q4 | $176M | Sell |
267,495
-700
| -0.3% | -$439K | 0.37% | 76 |
|
|
2021
Q3 | $167M | Sell |
268,195
-3,945
| -1% | -$2.65M | 0.39% | 68 |
|
|
2021
Q2 | $172M | Sell |
272,140
-2,713
| -1% | -$1.5M | 0.39% | 72 |
|
|
2021
Q1 | $134M | Sell |
274,853
-54,378
| -17% | -$27.2M | 0.34% | 75 |
|
|
2020
Q4 | $165M | Buy |
329,231
+1,070
| +0.3% | +$479K | 0.44% | 62 |
|
|
2020
Q3 | $129M | Buy |
328,161
+311,681
| +1,891% | +$115M | 0.4% | 66 |
|
|
2020
Q2 | $5.44M | Sell |
16,480
-310,302
| -95% | -$89.8M | 0.03% | 294 |
|
|
2020
Q1 | $79.2M | Sell |
326,782
-13,252
| -4% | -$3.46M | 0.34% | 78 |
|
|
2019
Q4 | $88.8M | Sell |
340,034
-1,815
| -0.5% | -$478K | 0.29% | 102 |
|
|
2019
Q3 | $93M | Sell |
341,849
-116,921
| -25% | -$32.5M | 0.33% | 89 |
|
|
2019
Q2 | $126M | Sell |
458,770
-23,588
| -5% | -$5.81M | 0.44% | 68 |
|
|
2019
Q1 | $108M | Buy |
482,358
+13,854
| +3% | +$2.86M | 0.42% | 79 |
|
|
2018
Q4 | $87.2M | Sell |
468,504
-15,560
| -3% | -$3.19M | 0.39% | 82 |
|
|
2018
Q3 | $121M | Sell |
484,064
-34,037
| -7% | -$8.26M | 0.46% | 69 |
|
|
2018
Q2 | $113M | Buy |
518,101
+103,186
| +25% | +$21.3M | 0.46% | 66 |
|
|
2018
Q1 | $79.4M | Sell |
414,915
-2,561
| -0.6% | -$473K | 0.35% | 86 |
|
|
2017
Q4 | $65.3M | Sell |
417,476
-3,010
| -0.7% | -$474K | 0.28% | 106 |
|
|
2017
Q3 | $65.4M | Buy |
+420,486
| New | +$66.5M | 0.3% | 92 |
|
Other funds holding IDXX
JSC
CIBC Private Wealth Group's IDXX Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Idexx Laboratories (IDXX) stake by 2.1% in Q4 2025, selling an estimated $5.22M and leaving 362,871 shares worth $245M. The position accounts for 0.42% of the portfolio, ranked #68.
CIBC Private Wealth Group first reported a position in IDXX in Q3 2017 and has held it in 34 quarters since. 1,385 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.
- CIBC Private Wealth Group held 362,871 shares of Idexx Laboratories worth $245M as of Q4 2025.
- CIBC Private Wealth Group sold 7,668 Idexx Laboratories shares in Q4 2025, an estimated $5.22M.
- Idexx Laboratories made up 0.42% of CIBC Private Wealth Group's portfolio in Q4 2025, its #68 holding.
- CIBC Private Wealth Group first reported a position in Idexx Laboratories in Q3 2017 and has held it in 34 quarters since.
- 1,385 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.